Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Carcinoma, Hepatocellular 1 Advanced Solid Tumor 1 Advanced Pancreatic Cancer 1

Interventions

Cisplatin 7 Gemcitabine 6 pembrolizumab 4 Radiotherapy, Intensity-Modulated 4 Bevacizumab 2 toripalimab 1 tocilizumab 1 tislelizumab 1 spartalizumab 1 penpulimab 1 atezolizumab 1 Vitamin D 1 Tablets 1 Surveys and Questionnaires 1 Phantoms, Imaging 1 Oral Hygiene 1 Observation 1 Magnetic Resonance Spectroscopy 1 Immunotherapy 1 Immunohistochemistry 1 Immunoglobulin G 1 Fluorouracil 1 Disulfides 1 Dexamethasone 1 Chemoradiotherapy 1 Cetuximab 1 Carboplatin 1 Capecitabine 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Nasopharyngeal Neoplasms × penpulimab × 1 year × Clear all

NCT05807880 2026-01-23

ALTER-HN005

Sun Yat-sen University

Phase 2 Active not recruiting

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡